These findings are of potential pathophysiological importance for understanding Arf6 which mechanistically behaves as a tumor promoter that leads to structural loss of adhesion and contributes to aggressive phenotypes in breast cancer. This evidence concerns the gene ARF6 and breast carcinoma.